Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.95 is in line with its 5-year average of 0.96, around the middle of its 5-year range (0.73–1.20).
As of the fiscal period ended Tuesday, June 30, 2026. 7.76% below its 12-month average of 1.03.
Reported quarterly quick ratio; no daily interpolation.
QUICK RATIO (ACID-TEST)
0.95
QUICK RATIO (ACID-TEST) AVG TTM
1.03
QUICK RATIO (ACID-TEST) AVG 3Y
1.02
QUICK RATIO (ACID-TEST) AVG 5Y
0.96
QUICK RATIO (ACID-TEST) AVG 10Y
0.98
QUICK RATIO (ACID-TEST) AVG 15Y
1.04
QUICK RATIO (ACID-TEST) AVG 20Y
1.08
CURRENT VS TTM AVG
-7.76%
CURRENT VS 3Y AVG
-7.09%
CURRENT VS 5Y AVG
-0.78%
CURRENT VS 10Y AVG
-3.42%
CURRENT VS 15Y AVG
-8.61%
CURRENT VS 20Y AVG
-11.94%
SECTOR MEDIAN · HEALTHCARE
1.27
median of 72 covered companies
CURRENT VS SECTOR MEDIAN
-25.37%
vs the sector median at left
Roche Holding AG
Market Cap
$359.46B
Quick Ratio (Acid-Test)
0.95
TTM Avg
1.03
3Y Avg
1.02
5Y Avg
0.96
Market Cap
$358.76B
Quick Ratio (Acid-Test)
N/A
TTM Avg
0.81
3Y Avg
0.80
5Y Avg
0.79
Market Cap
$369.34B
Quick Ratio (Acid-Test)
1.10
TTM Avg
1.23
3Y Avg
1.17
5Y Avg
1.09
Market Cap
$255.15B
Quick Ratio (Acid-Test)
0.67
TTM Avg
0.73
3Y Avg
0.70
5Y Avg
0.72
Market Cap
$234.38B
Quick Ratio (Acid-Test)
1.18
TTM Avg
1.41
3Y Avg
1.34
5Y Avg
1.37
Market Cap
$205.42B
Quick Ratio (Acid-Test)
0.66
TTM Avg
0.56
3Y Avg
0.61
5Y Avg
0.63
Market Cap
$193.04B
Quick Ratio (Acid-Test)
0.97
TTM Avg
1.21
3Y Avg
1.20
5Y Avg
1.26
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Roche Holding AG (RHHBY) | $359.46B | 0.95 | 1.03 | 1.02 | 0.96 |
| UnitedHealth Group Incorporated (UNH)vs › | $358.76B | N/A | 0.81 | 0.80 | 0.79 |
| Merck & Co., Inc. (MRK)vs › | $369.34B | 1.10 | 1.23 | 1.17 | 1.09 |
| AbbVie Inc. (ABBV)vs › | $455.87B | 0.69 | 0.56 | 0.68 | 0.69 |
| AstraZeneca PLC (AZN)vs › | $255.15B | 0.67 | 0.73 | 0.70 | 0.72 |
| Amgen Inc. (AMGN)vs › | $235.85B | 1.13 | 0.93 | 1.02 | 1.14 |
| Thermo Fisher Scientific Inc. (TMO)vs › | $234.38B | 1.18 | 1.41 | 1.34 | 1.37 |
| Novo Nordisk A/S (NVO)vs › | $205.42B | 0.66 | 0.56 | 0.61 | 0.63 |
| Abbott Laboratories (ABT)vs › | $193.04B | 0.97 | 1.21 | 1.20 | 1.26 |
| Gilead Sciences, Inc. (GILD)vs › | $184.82B | 1.09 | 1.42 | 1.32 | 1.28 |
Quick Ratio
0.95
Excludes inventory
Current Ratio
1.23
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 0.95 |
| 2025-12-31 | 1.12 |
| 2025-06-30 | 1.02 |
| 2024-12-31 | 1.20 |
| 2024-06-30 | 0.97 |
| 2023-12-31 | 1.04 |
| 2023-06-30 | 0.86 |
| 2022-12-31 | 0.93 |
| 2022-06-30 | 0.80 |
| 2021-12-31 | 0.73 |
| 2021-06-30 | 0.91 |
| 2020-12-31 | 1.01 |
| 2020-06-30 | 0.93 |
| 2019-12-31 | 1.04 |
| 2019-06-30 | 1.10 |
| 2018-12-31 | 1.11 |
| 2018-06-30 | 0.97 |
| 2017-12-31 | 1.09 |
| 2017-06-30 | 0.92 |
| 2016-12-31 | 0.92 |
| 2016-06-30 | 0.75 |
| 2015-12-31 | 0.86 |
| 2015-06-30 | 0.82 |
| 2014-12-31 | 1.01 |
| 2014-06-30 | 1.20 |
| 2013-12-31 | 1.48 |
| 2013-06-30 | 1.22 |
| 2012-12-31 | 1.28 |
| 2012-06-30 | 1.18 |
| 2011-12-31 | 1.43 |
| 2011-06-30 | 1.31 |
| 2010-12-31 | 1.51 |
| 2010-06-30 | 1.26 |
| 2009-12-31 | 1.49 |
| 2009-06-30 | 1.27 |
| 2008-12-31 | 2.71 |
| 2008-06-30 | 2.45 |
| 2007-12-31 | 2.54 |
| 2007-06-30 | 2.85 |
| 2006-12-31 | 2.78 |
| 2006-06-30 | 0.00 |
| 2005-12-31 | 3.22 |
| 2005-06-30 | 0.00 |
| 2004-12-31 | 2.51 |
| 2004-06-30 | 0.00 |
| 2003-12-31 | 2.11 |
| 2003-06-30 | 0.00 |
| 2002-12-31 | 1.63 |
| 2002-06-30 | 0.00 |
| 2001-12-31 | 2.12 |
| 2001-06-30 | 0.00 |
| 2000-12-31 | 2.09 |
| 2000-06-30 | 0.00 |
| 1999-12-31 | 1.89 |
| 1999-06-30 | 0.00 |
| 1998-12-31 | 1.93 |
| 1998-06-30 | 0.00 |
| 1998-01-31 | 0.00 |
